TrialThe Journal of infectious diseases2026

Safety and Immunogenicity of a Klebsiella pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V) Administered to Healthy Adults: A First-in-Human Phase I/II Randomized and Controlled Study.

C Alaimo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.